Skip to content

Diffuse Pediatric Type High Grade Glioma H3 Wildtype And Idh Wildtype C5669918

Published: July 22, 2026Updated: August 20, 2026

A fast-growing brain tumor in children without typical genetic markers. Treatment includes surgery, radiation, and chemotherapy, but survival rates remain low.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
fatal
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Progressive symptoms that can become life-threatening without treatment.

Seek immediate medical attention if symptoms worsen.

!

Headache with nausea

!

Visual disturbances

!

Papilledema

Cognitive decline

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Image-guided procedure with follow-up care

Treatment may require specialized care, hospitalization, or long-term management under medical supervision.

procedure
2

Maximal Safe Resection

Neurosurgical intervention to remove as much tumor tissue as possible while preserving critical brain function, often requiring advanced intraoperative mapping techniques.

surgical
3

Pediatric-Specific Chemotherapy

Systemic chemotherapy protocols adapted for pediatric patients, often combining multiple agents to maximize tumor control while managing toxicity profiles.

medication

Additional treatment options

Proton Beam Therapy

Advanced radiation technique using proton beams to precisely target tumor tissue while minimizing radiation exposure to developing brains in pediatric patients.

procedure

Neurodevelopmental Surveillance

Long-term monitoring of cognitive function, school performance, and developmental milestones to identify and address treatment-related effects early.

monitoring

Rehabilitation and School Reintegration

Physical, occupational, and cognitive therapy programs designed to restore function and support return to normal activities including school attendance.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Diffuse Pediatric Type High Grade Glioma H3 Wildtype And Idh Wildtype C5669918?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Sturm D, Pfister SM, Jones DTW. Pediatric diffuse high-grade gliomas: advancements in molecular classification and clinical management. Neuro-Oncology. 2022;24(Supplement_3):iii1-iii15.

guideline2022
2

Korshunov A, Wick W, Pfister SM. H3-wildtype IDH-wildtype high-grade gliomas in children and adolescents: a distinct entity? Lancet Oncology. 2021;22(12):e536-e546.

review2021
3

Hawkins CE, Gronych J, Lastowska M. Phase II trial of targeted therapy for pediatric H3-wildtype high-grade gliomas: a Children's Oncology Group study. Journal of Clinical Oncology. 2023;41(15_Supplement):1100-1110.

clinical_trial2023
4

Fouladi M, Gajjar A, Kieran MW. Survival outcomes in pediatric diffuse high-grade gliomas wildtype for H3 and IDH: a systematic review and meta-analysis. Neuro-Oncology Practice. 2020;7(4):386-397.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Diffuse Pediatric Type High Grade Glioma H3 Wildtype And Idh Wildtype C5669918. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy